Piracy by Patents The Case of The Neem Tree VANDANA SHIVA and RADHA HOLLABHAR
Piracy by Patents The Case of The Neem Tree VANDANA SHIVA and RADHA HOLLABHAR
PIRACY BY PATENT
The Case of the Neem Tree
Third World farmers over thousands of years were properly taken into
account, along with the discovery and care of plants with pharmaceutical
properties, the piracy accusation would be sharply reversed. The United
States would rightfully owe the Third World's farmers S3O2million an-
nually for royalties on farmers' seeds that the United States now uses and
$5.1 billion for pharmaceuticals now in U.S. drug stores.
Indian farmers understand the issue exquisitely well. They staged re-
peated mass demonstrations against the GATT Uruguay Round agree-
ment. In 1993, about a half-million farmers converged upon Bangalore to
voice their fears about the GATT legislation, fully aware of the direct
threat that it posed to their livelihoods.
In particular, many of them began to understand that the new GATT
institutionalizes the international "harmonization" of property rights leg-
islation and global monopoly ownership of life forms along the lines of
U.S. law.
Before GATT, Indian law excluded the private ownership of patent
rights and biological materials. This helped ensure that entitlements to
food and nutrition remained as broad-based as possible. But with GATT,
there is tremendous pressur~ to change. The inclusion of these living re-
sources in frameworks of private ownership of patents will threaten our
rights to survival as a country and as a people. Sovereignty in the matter of
patent law is essential because it is a matter of survival, especially for the
economically weaker sections of our society that have no purchasing
power and can be protected only through the public interest.
.Fuel. Neem oil is used as lamp oil, while the fruit pulp is useful in the
production of methane.
For centuries, the Western world ignored the neem tree and its proper-
ties. The practices of Indian peasants and doctors were not deemed wor-
thy of attention by the majority of British, French, and Portuguese
colonists. In the last few years, however, growing opposition to chemical
products in the West, in particular to pesticides, has led to a sudden new
interest in the pharmaceutical properties of neem.
In 1971, U.S. timber importer Robert Larson observed the tree's use-
fulness in India and began importing neem seed to his company head-
quarters in Wisconsin. Over the next decade, he conducted safety and
performance tests upon a pesticidal neem extract called Margosan-O and
in 1985 received clearance for the product from the u.s. Environmental
Protection Agency (EPA). Three years later, he sold the patent for the
product to the multinational chemical corporation, W. R. Grace and Co.
Since 1985, over a dozen U.S. patents have been taken out by U.S. and
Japanese firms on formulae for stable neem-based solutions and emul-
sions and even for a neem-based toothpaste. At least four of these are
owned by W. R. Grace; three are owned by another U.S. company, the
Native Plant Institute; and two by the JapaneseTerumo Corporation.
Having garnered their patents and with the prospect of a license from
the EPA, Grace set about manufacturing and commercializing the prod-
uct by establishing a base in India. The company approached several In-
dian manufacturers with proposals to buy up their technology or convince
them to stop producing their value-added pharmaceutical products and
instead to supply Grace with raw material.
In many cases,Grace met with a rebuff. M. N. Sukhatme, director of
Herringer Bright Chemicals Pvt. Ltd., which manufactures the neem-
based insecticide Indiara, was put under pressure by Grace to sell the
technology for a storage-stable neem extract that does not require heating
or any chemical change. Sukhatme refused their offers, stating, "I am not
interested to commercialize the product," (M. N. Sukhatme, personal
communication).
But Grace eventually managed to arrange a joint venture with a firm
called P. J. Margot Pvt. Ltd. The companies are now setting up a plant in
Piracy by Patent: The Caseof the Neem Tree 151
India that will process neem seed for export to the United States. Initially,
the plant will process 20 tons of seed per day. They are also setting up a
network of neem seed suppliers, to ensure a constant supply of seed and a
reliable price.
Grace is likely to be followed by other patent-holding companies. A
Scienct' magazine article ("The Wonders of the Neem Tree, Jan. 17, 1992),
stated that the U.S. National Research Council (NRC) published a report
designed to "open up the Western world's corporations to the seemingly
endless variety of products the tree might offer." According to one of the
members of the NRC panel, "In this day and age, when we're not very
happy about synthetic pesticides, (neem] has great appeal."
The appeal is blatantly commercial. The U .S. pesticides market is
worth about $2 billion annually. At the moment, biopesticides such as
pyrethrin, together with their synthetic mimics, constitute about 145°
million, but that figure is expected to rise to over $800 million by 1998.
PLAGIARISM OR INNOVATION?
the research and development that led to these patented compositions and
processes,they were considered sufficiently novel and different from the
original product of nature and the traditional method of use to be
patentable. ...Azadirachtin which was being destroyed during conven-
tional processing of Neem Oil/Neem Cake is being additionally extracted
in the form of Water Soluble Neem Extract and hence it is an add-on
rather than a substitute to the current neem industry in India."
In short, these corporate processes are supposedly novel advances on
Indian techniques. However, this novelty exists mainly in the context of
the ignorance of the West. Over the two thousand years that neem-based
biopesticides and medicines have been used in India, many complex
processeswere developed to make them available for specific use, though
the active ingredients were not given Latinized scientific names. In fact,
the widespread common knowledge and common use of neem was one of
the primary reasQnsgiven by the Indian Central Insecticide Board for not
registering neem products under the Insecticides Act of 1968. The board
argued that neem materials had been in extensive use in India for various
purposes since time immemorial, without any known deleterious effects.
The U.S. EPA, on the other hand, does not accept the validity of tradi-
tional knowledge and has imposed a full series of safety tests upon Mar-
gosan-O.
The allegation that azedirachtin was being destroyed during tradi-
tional processes is inaccurate. The extracts were subject to degradation
over time, but this was not a problem, since farmers make such extracts to
use when they need them. The problem of stabilization only arose when it
needed to be packaged and transported for a long time to be marketed
commercially.
Moreover, stabilization and other advances attributed to modern labo-
ratory technology had already been developed by Indian scientists in the
196os and 19705, well before U.S. and Japanese companies expressed an
interest. In a conversation with Dr. VandanaShiva, Dr. R. P. Singh of the
Indian Agricultural Research Institute asserted, "Margosan-O is a simple
Piracy by Patent: The Caseof the Neem Tree 153
ethanolic extract of neem seed kernel. In the late sixties we discovered the
potency of not only ethanolic extract but also other extracts of neem. ...
Work on the neem as pesticide originated from the division as early as
1962. Extraction techniques were also developed for a couple of years.
The azadirachtin-rich dust was developed by me."
The reluctance of Indian scientists to patent their inventions, thus leav-
ing their work vulnerable to piracy, may in part derive from a recognition
that the bulk of the work had already been accomplished by generations
of anonymous experimenters. This debt has yet to be acknowledged by
the u.s. patentees and their apologists. The April 1993 CRS report claims
that "the method of scattering ground neem seedsas a pesticide would not
be a patentable process, because this process. ..would be deemed obvi-
ous." Such a statement betrays either lamentable misjudgment or a racist
dismissal of indigenous knowledge. The discovery of neem's pesticidal
properties and of the means to process it was by no means "obvious" but
evolved through extended systematic knowledge development in non-
Western cultures. In comparison to this first nonobvious leap of knowl-
edge, the subsequent minor derivatives are quite "obvious" indeed.
and that wealth is created only when corporations commercialize the re-
sources used by local communities.
There is a growing awareness throughout India that the commoditiza-
tion of neem will result in its expropriation by multinational companies.
On August 15, 1995, on Indian Independence Day, farmers in the state of
Karnataka rallied outside the offices of the district collector in each district
to challenge the demands for "intellectual property rights" of multina-
tionals companies such as W. R. Grace. The farmers carried neem
branches as a symbol of collective indigenous knowledge.
Their ciimpaign has been supported by many noted Indian scientists.
Dr. R. P. Singh expressed to the authors his "whole [hearted] support [for
the] campaign against the globalization of Qeem." Dr. B. N. Dhawan,
emeritus scientist at the Central Drug Research Institute, maintains, "It is
really unfortunate that the benefits of all this work should go to an indi-
vidual or to a company. I sincerely hope that. ..the neem will continue to
remain available for use by people all over the world without paying a
high price to a company." Dr. V. P. Sharma, director of the Malaria Re-
search Institute, agrees: "We have discovered the repellent action of the
neem oil. ...There is no question of anybody else in India or outside tak-
ing a priority or patent on this aspect of neem oil. I would like this discov-
ery to be used as widely as possible to prevent nuisance from insect pests of
public health importance and in the prevention of the disease transmitted
by them."
GLOBAL TRIPS
The movement that has crystallized around the issue of neem patents rep-
resents a direct challenge to the attempt, in the Uruguay Round ofGATT,
to impose upon Third World countries the patent regime known as Trade
Related Intellectual Property (TRIPS), which already obtains in the
North. Before now, it was accepted internationally that different coun-
tries have different needs and priorities; each country is allowed to formu-
late its own patent laws, and the patents granted by or registered in the
country are applicable only there. However, developed nations, particu-
larly the United States, accuse Third World countries of engaging in "un-
fair trade practices" if they fail to adopt stringent patent laws. As part of
such accusations, the industrialized nations claim to have lost millions of
dollars due to "piracy" by the Third World.
Under the new GATT agreement, all this will change. Universaliza-
tion of the TRIPS regime under GATT means that national laws that
Piracy by Patent: Tht' Cast' oftht' Nt't'm Trt't' 155
African Soapberry
Another plant that, like neem, has been at the center of attention is
the African Soapberry of endod (Phytdacca dodecandra}. Its proper-
ties as an insecticidal soap, a fish intoxicant and a spermicidal con-
traceptive have long been known to Africans, but in 1964, the
Ethiopian Dr. Aklilu Lemma reported to the Tropical Products In-
stitute in Britain that it killed the water-snails that are the only vec-
tor of the disease, bilharzia. He was subsequently alarmed to find
out that in his absence the Institute patented an extraction process
without consulting him or crediting him. Northern companies are
not interested in endod as a preventative for bilharzia in the Third
World {which is the province of Baylucide, an expensive and muta-
genic German chemical molluscicide), but for use in toxically sensi-
tive situations in the North -in particular, to kill zebra mussel
which clog North American water pipes and disrupt U.S. fisheries.
Patenting endod means that the people of Ethiopia and other
African countries will receive no roy~lties and may eventually be
deprived of the free use of the plant, as it will be needed for the
commercial productio.n of molluscicide for the U.S.
Cotton
Patents on life forms can be very wide-ranging. A subsidiary of
w. R. Grace, Agracetus Inc., has taken out U.S. patents which cover
all genetically engineered cotton varieties until 2008, and has the
patent pending in Europe, Brazil, China and India. The patents
cover methods of inserting genes into cotton using both bacteria
and "gene gun" technology. Agracetus' vice-president of finance,
Russel Smestad, claims: " All transgenic cotton products, regardless
of which engineering technique is used, will have to be commer-
cially licensed through us before they can enter the marketplace."
The patent has provoked a chorus of objections from scientists and
156 VANDANA SHIVA AND RADHA HOLLA-BHAR
Patent Banks
For Third World countries, all of these corporate monopolies over neem
and also other life forms will have numerous negative consequences.
Firstly, it will undermine our cultural and ethical fabric that supports our
agriculture. We have viewed fundamental life processes as sacred, not as
commodities to be bought and sold on the market. The sacred cow will
give way to patented and cloned livestock. {According to U.S. patent law,
the offspring of patented livestock would also be subject to royalty charges
throughout the seventeen to twenty-two years of patent protections, so
that farmers will be made to pay royalties each time a calf is born.) And
seeds,which have been traditionally treated as sacred gifts from Earth ex-
changed freely between farmers, will become patented commodities that
Third World farmers will have to buy. Hans Lenders, secretary general of
the world seed houses and their breeders, has actually proposed to abolish
farmers' rights to save seed. He says, "Even though it has been a tradition
in most countries that a farmer can save seed from his own crop, it is,
under the chilnging circumstances, not equitable that a farmer can use
this seed and grow a commercial crop out of it without payment of roy-
alty. ...[T]he seed industry will have to fight hard for a better kind of
Piracy by Patent: The Caseof the Net'm Tree 157
."
protectIon.
AFTERWORD
In June 1995, the Upper House of the Indian Parliament (Rajya Sabha)
forced the government to defer indefinitely a "patent amendment" bill the
government had proposed. That government bill would have brought
India into "compliance" with GATT and the WTO's new rules concern-
ing intellectual property rights.
The deferment of the patent bill created an unprecedented situation.
The legislature of the largest democracy in the world has gone in one di-
rection, while the central government feels it must alter its nation's laws to
conform to the WTO.
As this chapter goes to press (February 1996), India's laws still do not
permit product patents in pharmaceuticals and agriculture. The indigenous
farmers of India, through their protest activities about neem and other
seeds,deserve full credit for this remarkable development.
whether the Indian government can find ways to circumvent the parlia-
ment and the farmers, remains to be seen. But Indian refusal to comply
thus far with the WTO has the potential for creating a grave crisis for an
organization not accustomed to such democratic challenges.